The Lancet
Metrics for diplomats: is mortality from non-communicable diseases increasing or decreasing?
Article
03 Jul 2025
Scoping Review of Economic Analyses of Rare Kidney Diseases
International Society of Nephrology
10 Dec 2024
Rare kidney diseases (RKDs) place a substantial economic burden on patients and health systems, the extent of which is unknown and may be systematically underestimated by health economic techniques. We aimed to investigate the economic burden and cost-effectiveness evidence base for RKDs.
